ALKERMES, INC.

Lobbying client · Massachusetts · filed 2025 to 2026

Pharmaceutical manufacturing and biopharmaceutical company.

$450,000 Reported spend

6 Filings counted

1 Firms hired

2 Bills named

Spend is reported income plus in-house expenses across 6 filings. Everything on this page is grouped by the client's LDA id (196192), not by name.

Firms hired 1

PENN AVENUE PARTNERS $450,000 6 filings

Bills named in these filings 2

HR 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

1 filing
HR 8469
Making appropriations for military construction, the Department of Veterans Affairs, and related agencies for…

1 filing

Reported by year 2 years

2026 $160,000 2 filings
2025 $290,000 4 filings

Issues lobbied 1

Pharmacy 6

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 3

HOUSE OF REPRESENTATIVES 6
SENATE 6
Veterans Affairs, Dept of (VA) 5

Recent filings 6 total

Q2

PENN AVENUE PARTNERS

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $80,000 income · posted Jul 7, 2026

View → Q1

PENN AVENUE PARTNERS

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $80,000 income · posted Apr 2, 2026

View → Q4

PENN AVENUE PARTNERS

4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $80,000 income · posted Jan 9, 2026

View → Q3

PENN AVENUE PARTNERS

3rd Quarter (July 1 - Sep 30) 2025 · House · Senate · $80,000 income · posted Oct 3, 2025

View → Q2

PENN AVENUE PARTNERS

2nd Quarter (Apr 1 - June 30) 2025 · House · Senate · $70,000 income · posted Jul 9, 2025

View → Q1

PENN AVENUE PARTNERS

1st Quarter (Jan 1 - Mar 31) 2025 · House · Senate · $60,000 income · posted Apr 16, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.